449 related articles for article (PubMed ID: 25232236)
1. Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.
Nakamura J; Tanaka T; Kitajima Y; Noshiro H; Miyazaki K
World J Gastroenterol; 2014 Sep; 20(34):11991-2006. PubMed ID: 25232236
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.
Matuszcak C; Haier J; Hummel R; Lindner K
World J Gastroenterol; 2014 Oct; 20(38):13658-66. PubMed ID: 25320504
[TBL] [Abstract][Full Text] [Related]
3. Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer.
Sawaki K; Kanda M; Kodera Y
Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):657-670. PubMed ID: 29902383
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
Ahadi A
IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the molecular diagnostics of gastric cancer.
Kanda M; Kodera Y
World J Gastroenterol; 2015 Sep; 21(34):9838-52. PubMed ID: 26379391
[TBL] [Abstract][Full Text] [Related]
6. Zic1 Promoter Hypermethylation in Plasma DNA Is a Potential Biomarker for Gastric Cancer and Intraepithelial Neoplasia.
Chen X; Lin Z; Xue M; Si J; Chen S
PLoS One; 2015; 10(7):e0133906. PubMed ID: 26207911
[TBL] [Abstract][Full Text] [Related]
7. Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer.
Amini M; Hejazi M; Ghorban K; Mokhtarzadeh A; Baradaran B
Gene; 2021 Mar; 772():145376. PubMed ID: 33359128
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
[TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
Coppedè F; Lopomo A; Spisni R; Migliore L
World J Gastroenterol; 2014 Jan; 20(4):943-56. PubMed ID: 24574767
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
Pan HX; Bai HS; Guo Y; Cheng ZY
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
[TBL] [Abstract][Full Text] [Related]
11. Pathogenetic mechanisms in gastric cancer.
Shi J; Qu YP; Hou P
World J Gastroenterol; 2014 Oct; 20(38):13804-19. PubMed ID: 25320518
[TBL] [Abstract][Full Text] [Related]
12. CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker.
Amini M; Ghorban K; Mokhtarzadeh A; Dadmanesh M; Baradaran B
Life Sci; 2020 Aug; 254():117774. PubMed ID: 32407843
[TBL] [Abstract][Full Text] [Related]
13. eIF4EBP3 was downregulated by methylation and acted as a tumor suppressor by targeting eIF4E/β-catenin in gastric cancer.
Zhai S; Lin S; Lin Z; Xu J; Ji T; Chen K; Wu K; Liu H; Ying H; Fei W; Wang J; Fu G; Wang Y; Hu X; Cai X
Gastric Cancer; 2020 May; 23(3):483-496. PubMed ID: 31853750
[TBL] [Abstract][Full Text] [Related]
14. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer.
Ivanova T; Zouridis H; Wu Y; Cheng LL; Tan IB; Gopalakrishnan V; Ooi CH; Lee J; Qin L; Wu J; Lee M; Rha SY; Huang D; Liem N; Yeoh KG; Yong WP; Teh BT; Tan P
Gut; 2013 Jan; 62(1):22-33. PubMed ID: 22535375
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation in cancer: a gene silencing mechanism and the clinical potential of its biomarkers.
Fukushige S; Horii A
Tohoku J Exp Med; 2013 Mar; 229(3):173-85. PubMed ID: 23419314
[TBL] [Abstract][Full Text] [Related]
16. Review of recent molecular landscape knowledge of gastric cancer.
Shimizu D; Kanda M; Kodera Y
Histol Histopathol; 2018 Jan; 33(1):11-26. PubMed ID: 28447336
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.
Yang Z; Guo X; Li G; Shi Y; Li L
Cancer Lett; 2016 Feb; 371(1):62-70. PubMed ID: 26577810
[TBL] [Abstract][Full Text] [Related]
18. Identification of the subtypes of gastric cancer based on DNA methylation and the prediction of prognosis.
Li T; Chen X; Gu M; Deng A; Qian C
Clin Epigenetics; 2020 Oct; 12(1):161. PubMed ID: 33115518
[TBL] [Abstract][Full Text] [Related]
19. Early Epigenetic Markers for Precision Medicine.
Dumitrescu RG
Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
[TBL] [Abstract][Full Text] [Related]
20. DNA and histone methylation in gastric carcinogenesis.
Calcagno DQ; Gigek CO; Chen ES; Burbano RR; Smith Mde A
World J Gastroenterol; 2013 Feb; 19(8):1182-92. PubMed ID: 23482412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
